| 序号 |
商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型 |
规格 |
参比药物 |
参比标准 |
申请号批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| 1 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
1 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
20MG/10ML (2MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 2 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
2 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
40MG/20ML (2MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 3 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
3 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
100MG/20ML (5MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 4 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
4 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
100MG/10ML (10MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 5 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
5 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
150MG/30ML (5MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 6 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
6 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
150MG/20ML (7.5MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 7 |
ROPIVACAINE HYDROCHLORIDE |
218713 |
7 |
ANDA |
ROPIVACAINE HYDROCHLORIDE |
SOLUTION;INJECTION |
200MG/20ML (10MG/ML) |
No |
No |
2024-07-30 |
2024-07-30 |
KINDOS |
Prescription |
| 8 |
BROMFENAC SODIUM |
210962 |
1 |
ANDA |
BROMFENAC SODIUM |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.07% ACID |
No |
No |
2024-07-29 |
2024-07-29 |
AMNEAL |
Prescription |
| 9 |
TEZRULY |
218139 |
1 |
NDA |
TERAZOSIN HYDROCHLORIDE |
SOLUTION;ORAL |
EQ 1MG BASE/ML |
Yes |
Yes |
2024-07-29 |
2024-07-29 |
NOVITIUM PHARMA |
Prescription |
| 10 |
LISDEXAMFETAMINE DIMESYLATE |
202836 |
1 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
CAPSULE;ORAL |
20MG |
No |
No |
2024-07-26 |
2024-07-26 |
SANDOZ |
Prescription |